EcoDrugPlus

Ribosomal Protein S26

Ensembl ID : ENSNFUG00015010401
Gene Symbol: RPS26
1 Cross references
405 Possible Orthologues:

Ribosomal Protein S28

Ensembl ID : ENSNFUG00015020238
Gene Symbol: RPS28
3 Cross references
274 Possible Orthologues:

Ribosomal Protein S3

Ensembl ID : ENSNFUG00015015649
Gene Symbol: RPS3
3 Cross references
499 Possible Orthologues:

Ribosomal Protein S3a

Ensembl ID : ENSNFUG00015012205
Gene Symbol: RPS3A
3 Cross references
360 Possible Orthologues:

Ribosomal Protein S5

Ensembl ID : ENSNFUG00015011780
Gene Symbol: RPS5
3 Cross references
264 Possible Orthologues:

Ribosomal Protein S7

Ensembl ID : ENSNFUG00015013584
Gene Symbol: RPS7
3 Cross references
357 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSNFUG00015014391
Gene Symbol: RPS9
3 Cross references
235 Possible Orthologues:

Ribosomal Protein Sa

Ensembl ID : ENSNFUG00015001374
Gene Symbol: RPSA
3 Cross references
515 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSNFUG00015011674
Gene Symbol: LOC107385505
3 Cross references
398 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P1

Ensembl ID : ENSNFUG00015011322
Gene Symbol: RPLP1
3 Cross references
382 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-1-Like

Ensembl ID : ENSNFUG00015011265
Gene Symbol: LOC107391354
3 Cross references
246 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSNFUG00015006091
Gene Symbol: SERPINC1
3 Cross references
199 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).